Benzamides derived from 1,2-diaminocyclopropane as novel ligands for human D2 and D3 dopamine receptors

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 2, 2000, Pages 321-327

  Yang, Donglai ^a   Kefi, Slaheddine ^a   Audinot, Valérie ^b   Millan, Mark J ^b   Langlois, Michel ^a  

^a CNRS   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

1,2 diaminocyclopropane; Benzamides; BRL 25594; D2; D3; Dopamine receptor antagonists; Receptors

Indexed keywords

4 AMINO N [2 (N BENZYL N METHYLAMINO) 1 CYCLOPROPYL] 5 CHLORO 2 METHOXYBENZAMIDE; BENZAMIDE DERIVATIVE; CYCLOPROPANE DERIVATIVE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CORPUS STRIATUM; DRUG BINDING SITE; DRUG CONFORMATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOMERISM; NONHUMAN; REACTION ANALYSIS;

ANIMALS; BENZAMIDES; CATTLE; CHO CELLS; CRICETINAE; CYCLOPROPANES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; RADIOLIGAND ASSAY; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

ANIMALIA; BOVINAE; STAPHYLOCOCCUS PHAGE 3A;

EID: 0034000794     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00281-3     Document Type: Article

References (26)

1. Briejer M.R., Akkermans L.M.A., Schuurkes J.A. J. Pharmacol. Rev. 47:1995;631.
2. de Paulis, T. In VIIIth International Symposium on Medicinal Chemistry, Proceeding I; Dahlborn, R.; Nilsson, J. L. G., Eds.; 1985; pp 2-28.
3. Pinder R.M., Brodgen R.N., Sawyer P.R., Speight T.M., Avery G. Drugs. 12:1976;81.
4. Justin-Besancon L., Laville C., Thominet M. C. R. Acad. Sci. Paris. 256:1964;4384.
5. Yang D., Brémont B., Shen S., Kefi S., Langlois M. Eur. J. Med. Chem. 31:1996;231.
6. Imbert, T.; Dorme, N.; Langlois, M. European Patent 0099789 A1.
7. Fake C.S., King F.D., Sanger G.J. Br. J. Pharmacol. 91:1987;335P.
8. Hadley, M. S. In Chemical Regulation of Biological Mechanisms; Creighton, A. M.; Turner, S., Eds.; Royal Society of Chemistry: London, 1982; pp 140-153.
9. King F.D., Hadley M.S., McClelland C.M. J. Med. Chem. 31:1988;1708.
10. Brown F., Campbell W., Clark M.S.G., Graves D.S., Hadley M.S., Hatcher J., Mitchell P., Needham P., Riley G., Semple J. Psychopharmacology. 94:1988;350.
11. Langlois M., Yang D., Brémont B., Shen S. Bioorg. Med. Chem. Lett. 5:1995;795.
12. Flynn D.L., Zabrowski D.L., Becker D.P., Nosal R., Villamil C.I., Gullikson G.W., Moummi C., Yang D.C. J. Med. Chem. 35:1992;1486.
13. Collin S., El Tayar N., Van de Waterbeemd H., Moureau F., Vercauteren D.P., Durant F., Langlois M., Testa B. Eur. J. Med. Chem. 24:1989;163.
14. Gaster L.M., King F.D. Med. Res. Rev. 17:1997;163.
15. Paine G.B. J. Org. Chem. 32:1967;3351.
16. Witiak D.T., Lee H.J., Hart R.W., Gibson R.E. J. Med. Chem. 20:1977;630.
17. Witiak D.T., Lee H.J., Goldman H.D., Zwilling B.S. J. Med. Chem. 21:1978;1194.
18. Majchrzak M.W., Kotelko A., Guryn R. Synth. Comm. 11:1981;493.
19. Yang D., Soulier J-L., Sicsic S., Mathé-Allainmat M., Brémont B., Croci T., Cardamone R., Aureggi G., Langlois M. J. Med. Chem. 40:1997;608.
20. Borch R.F., Bernstein M.D., Durst H.D. J. Am. Chem. Soc. 93:1971;2897.
21. Creese, I.; Hess E. J. In Receptor Binding in Drug Research; O'Brien, R. A., Ed.; New York: Marcel Dekker, 1986; pp 123-149.
22. Sokoloff P., Andrieux M., Besançon R., Pilon C., Martres M.-P., Giros B., Schwartz J.-C. Eur. J. Pharmacol. 225:1992;331.
23. Dostert Ph., Imbert T., Langlois M., Bucher B., Mocquet G. Eur. J. Med. 19:1984;105.
24. Durant F.; De Beys, V.; Collin, S.; Evrard, G. Bull. Soc. Chim. 1986, 497.
25. Petterson I., Liljefors T. J. Med. Chem. 35:1992;2355.
26. Furuya T., Iwanami S., Takenaka A., Sasada Y. Bull. Chem. Soc. Jpn. 55:1982;2321.